@article{362ae734ecfb4c16ac33333732dac56e,
title = "Levetiracetam for bipolar disorder: Consideration from a systematic review",
author = "Taro Kishi and Hiromi Hayakawa and Yui Kawamoto and Yosuke Nakao and Tae Narita and Kazuhiro Nishimoto and Kenji Sakuma and Nakao Iwata",
note = "Funding Information: The authors have declared that there are no conflicts of interest relating to the subject of this study. Interests from the past 3 years are as follows. Dr. Kishi received speaker's honoraria from Sumitomo, Otsuka, Eisai, Viatris, Daiichi Sankyo, Takeda, Kyowa, Meiji, Eli Lilly, and Janssen; and research grants from Eisai, the Japanese Ministry of Health, Labour and Welfare, Grant‐in‐Aid for Scientific Research (C), and Fujita Health University School of Medicine. Ms. Hayakawa, Ms. Kawamoto, Mr. Nakao, Ms. Narita, and Mr. Nishimoto had no conflicts of interest with any company. Dr. Sakuma has received speaker's honoraria from Sumitomo, Meiji, and Otsuka, and has received a Fujita Health University School of Medicine Research Grant for Early‐Career Scientists, as well as a Grant‐in‐Aid for Young Scientists (B). Prof. Iwata received speaker's honoraria from Sumitomo, Eli Lilly, Janssen, Meiji, Otsuka, Takeda, and Viatris and research grants from Daiichi Sankyo, Takeda, Sumitomo, Eisai, Tanabe‐Mitsubishi, and Otsuka. ",
year = "2022",
month = dec,
doi = "10.1111/bdi.13255",
language = "English",
volume = "24",
pages = "834--835",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "8",
}
SDG 3 Good Health and Well-being